Amalgamated Bank Sarepta Therapeutics, Inc. Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

A detailed history of Amalgamated Bank transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 44,959 shares of SRPT stock, worth $1.75 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
44,959
Previous 46,695 3.72%
Holding current value
$1.75 Million
Previous $5.68 Million 49.47%
% of portfolio
0.02%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
SELL
$63.82 - $127.89 $110,791 - $222,017
-1,736 Reduced 3.72%
44,959 $2.87 Million
Q4 2024

Feb 04, 2025
BUY
$104.54 - $137.94 $23,207 - $30,622
222 Added 0.48%
46,695 $5.68 Million
Q3 2024

Oct 30, 2024
SELL
$124.33 - $156.75 $279,493 - $352,374
-2,248 Reduced 4.61%
46,473 $5.8 Million
Q2 2024

Aug 12, 2024
BUY
$113.33 - $163.85 $4.85 Million - $7.01 Million
42,813 Added 724.66%
48,721 $7.7 Million
Q1 2024

Apr 23, 2024
SELL
$93.7 - $141.53 $1.15 Million - $1.74 Million
-12,260 Reduced 67.48%
5,908 $765,000
Q4 2023

Feb 06, 2024
SELL
$67.31 - $124.76 $155,755 - $288,694
-2,314 Reduced 11.3%
18,168 $1.75 Million
Q3 2023

Nov 08, 2023
BUY
$102.5 - $123.59 $127,407 - $153,622
1,243 Added 6.46%
20,482 $2.48 Million
Q2 2023

Aug 11, 2023
BUY
$106.4 - $157.19 $163,856 - $242,072
1,540 Added 8.7%
19,239 $2.2 Million
Q1 2023

May 02, 2023
SELL
$117.53 - $155.99 $208,850 - $277,194
-1,777 Reduced 9.12%
17,699 $2.44 Million
Q4 2022

Feb 10, 2023
BUY
$100.86 - $132.13 $24,307 - $31,843
241 Added 1.25%
19,476 $2.52 Million
Q3 2022

Nov 09, 2022
BUY
$75.71 - $119.24 $23,621 - $37,202
312 Added 1.65%
19,235 $2.13 Million
Q2 2022

Aug 15, 2022
SELL
$62.69 - $88.44 $15,797 - $22,286
-252 Reduced 1.31%
18,923 $1.42 Million
Q1 2022

Jun 30, 2022
BUY
$63.15 - $90.42 $113,227 - $162,123
1,793 Added 10.32%
19,175 $1.5 Million
Q4 2021

Feb 15, 2022
BUY
$77.28 - $99.42 $275,425 - $354,332
3,564 Added 25.79%
17,382 $1.57 Million
Q3 2021

Oct 29, 2021
SELL
$65.97 - $92.48 $55,480 - $77,775
-841 Reduced 5.74%
13,818 $1.28 Million
Q2 2021

Aug 16, 2021
BUY
$69.38 - $86.75 $45,097 - $56,387
650 Added 4.64%
14,659 $1.14 Million
Q1 2021

May 13, 2021
SELL
$72.25 - $168.95 $88,361 - $206,625
-1,223 Reduced 8.03%
14,009 $1.04 Million
Q4 2020

Feb 12, 2021
BUY
$125.56 - $178.74 $22,851 - $32,530
182 Added 1.21%
15,232 $2.6 Million
Q3 2020

Oct 30, 2020
SELL
$127.12 - $172.34 $49,195 - $66,695
-387 Reduced 2.51%
15,050 $2.11 Million
Q2 2020

Aug 10, 2020
SELL
$93.0 - $171.7 $294,903 - $544,460
-3,171 Reduced 17.04%
15,437 $2.48 Million
Q1 2020

May 13, 2020
SELL
$82.38 - $131.64 $44,320 - $70,822
-538 Reduced 2.81%
18,608 $1.82 Million
Q4 2019

Feb 13, 2020
BUY
$76.53 - $135.58 $113,647 - $201,336
1,485 Added 8.41%
19,146 $2.47 Million
Q3 2019

Nov 13, 2019
BUY
$72.81 - $156.91 $150,207 - $323,705
2,063 Added 13.23%
17,661 $1.33 Million
Q2 2019

Aug 14, 2019
BUY
$112.21 - $151.95 $49,372 - $66,858
440 Added 2.9%
15,598 $2.37 Million
Q1 2019

May 15, 2019
BUY
$106.67 - $151.68 $30,294 - $43,077
284 Added 1.91%
15,158 $1.81 Million
Q4 2018

Feb 15, 2019
BUY
$97.32 - $148.76 $613,116 - $937,188
6,300 Added 73.48%
14,874 $1.62 Million
Q3 2018

Nov 14, 2018
SELL
$115.31 - $161.51 $679,406 - $951,616
-5,892 Reduced 40.73%
8,574 $1.39 Million
Q2 2018

Jul 18, 2018
BUY
$71.74 - $153.69 $453,827 - $972,242
6,326 Added 77.71%
14,466 $1.91 Million
Q1 2018

May 22, 2018
SELL
$54.02 - $82.27 $7,616 - $11,600
-141 Reduced 1.7%
8,140 $603,000
Q4 2017

Feb 13, 2018
BUY
$47.64 - $56.75 $37,302 - $44,435
783 Added 10.44%
8,281 $461,000
Q3 2017

Nov 09, 2017
BUY
$35.73 - $47.15 $267,903 - $353,530
7,498
7,498 $340,000

Others Institutions Holding SRPT

# of Institutions
508
Shares Held
88.9M
Call Options Held
1.39M
Put Options Held
1.13M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $3.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email